Latest Breaking News On - Maruho obtained regulatory approval - Page 1 : comparemela.com

Maruho Obtained Regulatory Approval for Mitchga, the First Antibody Targeting IL-31 for Itching Associated with Atopic Dermatitis

Japan generalUnited kingdomChugai nemolizumabOsamu okudaChugai pharmaceutical co ltdEngland journal of medicine onlineChugai pharmaceutical coAtopic dermatitisMinistry of healthMaruho co ltdIchugai pharmaceutical co ltdMaruho obtained regulatory approvalFirst antibody targetingItching associatedJapani marchSubcutaneous injection